UBIC Builds NARO Anti-tick Vaccine Team's Capacity for Biosafety ComplianceJanuary 6, 2021
The Uganda Biosciences Information Centre (UBIC) has taken steps to build the capacity of the anti-tick vaccine (ATV) development team of Uganda's National Agricultural Research Organisation (NARO) in communication and biosafety compliance.
Starting December 2, 2020, UBIC has conducted a series of training with the ATV team which has culminated in the development of a communication strategy and boosted the team's capacity to uphold regulatory requirements established by the National Biosafety Committee (NBC) in the conduct of their work. It is important to build the communication function of the project so that you begin to communicate in a way that facilitates public understanding about the product (vaccine) advised Dr. Titus Alicai, a Principal Research Officer at NARO and the Principal Investigator of the Virus Resistant Cassava for Africa (VIRCAPlus) project. VIRCAPlus is developing cassava varieties with resistance to cassava brown streak and cassava mosaic diseases using genetic engineering tools.
Dr. Barbara Zawedde, Director of Research at NARO's Mukono Zonal Agricultural Research and Development Institute (MuZARDI) and NARO Institutional Biosafety Committee Chair advised the team to ensure that IP issues are clarified and streamlined to avoid future encumbrances.
Results from these training including communication strategies and Standard Operating Procedures will be key for the ATV team as they develop a dossier required for biosafety clearance for commercialization of the vaccine. They will also be of benefit, as benchmarks to other teams conducting similar work in Uganda. The training was attended by 14 members of the ATV team. More training is in the pipeline to equip the entire team, including support staff with the requisite knowledge on biosafety and regulatory compliance.
For more details, contact the UBIC Coordinator at email@example.com.
You might also like:
- UBIC Initiates Efforts to Integrate Biosciences into Uganda's Education System
- Government Spokespersons Impressed by Progress in Agri-biotech Research in Uganda
- Curriculum Reforms in Uganda Integrate Modern Biosciences
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- ISAAA Presents 2019 Biotech Adoption Findings to Stakeholders in Europe and South America
- UBIC Builds NARO Anti-tick Vaccine Team's Capacity for Biosafety Compliance
- CIMMYT Announces Fall Armyworm Tolerant Maize Hybrids for Africa
- Researchers Find Flag Leaves Top Off Rice Photosynthetic Performance
- USDA APHIS Deregulates GE Corn with Enhanced Yield and Herbicide Tolerance Traits
- Price, Nutrition Among Top Factors that Affect Canadian Consumers' Choice to Buy GM Foods
- Scientists Boost Vegetable Oil Production in Plant Leaves
- CSIRO "Gene Sandwich" to Boost Wheat Resistance to Rust
- Bt Cotton Key in Eradicating Destructive Pest from the US and Mexico
- Target-AID and CRISPR-Cas9 Improve Lycopene Content in Tomatoes
- What are TALENs?
- Fast-spreading SARS-CoV-2 Variant in the U.K. Raises More Questions
Read the latest:
- Biotech Updates (November 22, 2023)
- Gene Editing Supplement (November 15, 2023)
- Gene Drive Supplement (February 22, 2023)
Subscribe to BU: